Stock page
Braeburn Pharmaceuticals Inc (BBRX)
Braeburn Pharmaceuticals Inc is a US-based commercial-stage pharmaceutical company. Its core business is to focus on the development and commercialization of novel long-acting medications for serious disorders of the central nervous system (CNS). It provides differentiated solutions for chronic diseases with high unmet medical needs through its implantable and injectable delivery mechanisms. The company focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. Its product includes Probuphine which is the implantable formulation of buprenorphine for the maintenance treatment of opioid addiction.
Quote snapshot
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|